PINE MOUNTAIN, Ga., Dec. 17, 2025 /PRNewswire/ — HomeTown Health, LLC held its 26th Annual Fall Conference at Callaway Gardens in Pine Mountain, Georgia, October 22-24, 2025. The annual event includes breakout sessions and presentations from industry experts, established public figures and healthcare leaders on a local and state level. Additionally, it is a time… Continue reading HomeTown Health Honors Rural Georgia Hospital Leaders in 2025 Graduation & Awards Ceremony
Tag: Strategy
Two New Directors Join atNorth as Growth Drive Continues
The business has appointed a Director of Public Affairs and Communications, and a Director of HSE, as it continues to scale in response to increasing demand for its services. REYKJAVÍK, Iceland, Dec. 17, 2025 /PRNewswire/ — atNorth, the leading Nordic high-density colocation and built-to-suit datacenter provider, has announced two new Director appointments that enhance the company’s… Continue reading Two New Directors Join atNorth as Growth Drive Continues
AZIO AI Valuation at Approximately $480 Million Enterprise Value, Underscoring Rapid Emergence as a Critical AI Infrastructure Platform
Independent valuation highlights accelerating revenue, expanding GPU compute scale, and strategic transaction momentum, including ongoing engagement with Envirotech Vehicles, Inc. (NASDAQ: EVTV) LOS ANGELES, Dec. 17, 2025 /PRNewswire/ — AZIO AI Corporation (“AZIO” or the “Company”), a rapidly scaling artificial intelligence and high-performance computing infrastructure platform, today announced the completion of an independent valuation analysis,… Continue reading AZIO AI Valuation at Approximately $480 Million Enterprise Value, Underscoring Rapid Emergence as a Critical AI Infrastructure Platform
Slone Partners Places Jeffrey Kasten as Chief Business Officer at Vertero Therapeutics
Experienced executive will focus on driving business development, strategic partnerships, corporate and portfolio strategy, and commercialization planning SOUTH RIDING, Va., Dec. 17, 2025 /PRNewswire/ — Slone Partners, a nationwide executive search firm for life sciences and healthcare organizations, has announced the placement of Jeffrey S. Kasten as Chief Business Officer (CBO) at Vertero Therapeutics, a clinical-stage… Continue reading Slone Partners Places Jeffrey Kasten as Chief Business Officer at Vertero Therapeutics
Biologics X 3DCC Conference 2026: Merging Innovation, Drug Development, and Translation for the Next Era of Biopharma
Registrations OPEN India’s first of-its-kind, 6th Annual Summit on Biopharmaceutical Product Development in conjunction with the 3rd edition of the International Conference on Advances in 3D Cell Culture. Date & Venue: January 22-23, 2026, | Novotel Dona Sylvia Resort, Goa, India MUMBAI, India and GOA, India, Dec. 17, 2025 /PRNewswire/ — The Mumbai Biocluster, in association… Continue reading Biologics X 3DCC Conference 2026: Merging Innovation, Drug Development, and Translation for the Next Era of Biopharma
XCMG Announces Completion and Handover of Sixth-Phase Africa Water Cellar Project
From Access to Empowerment: Over 237 Water Cellars Deliver Sustainable Hope in Africa XUZHOU, China, Dec. 17, 2025 /PRNewswire/ — XCMG has announced the completion and handover of the sixth phase of the Africa Water Cellar Project in Ethiopia, a global public-welfare initiative jointly launched by XCMG and the China Foundation for Rural Development (CFRD).… Continue reading XCMG Announces Completion and Handover of Sixth-Phase Africa Water Cellar Project
@niche: INEOS announces £150 million investment at its Grangemouth site, supported by the UK Government, to secure the future of British industry.004200
INEOS is investing £150m at its Grangemouth site, supported by a £75m Government loan guarantee and £50m grant At a time when British manufacturing is in decline, this investment, in partnership with the UK Government, maintains the operation of Grangemouth as a critical and strategic supplier to UK industry. Government support shows the strategic importance… Continue reading @niche: INEOS announces £150 million investment at its Grangemouth site, supported by the UK Government, to secure the future of British industry.004200
Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology
Agreement underscores Norgine’s mission to bring innovative therapies to patients and builds on our heritage in hepatology and specialty pharmaceuticals. Vir Biotechnology’s chronic hepatitis delta treatment candidate has shown robust virological responses and reflects a differentiated approach to treatment. UXBRIDGE, England, Dec. 17, 2025 /PRNewswire/ — Norgine, a leading European specialty pharmaceutical company, today announced… Continue reading Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology
Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology
Agreement underscores Norgine’s mission to bring innovative therapies to patients and builds on our heritage in hepatology and specialty pharmaceuticals. Vir Biotechnology’s chronic hepatitis delta treatment candidate has shown robust virological responses and reflects a differentiated approach to treatment. UXBRIDGE, England, Dec. 17, 2025 /PRNewswire/ — Norgine, a leading European specialty pharmaceutical company, today announced… Continue reading Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology
Netwatch Announces Agreement to Be Acquired by GI Partners
LAKE FOREST, Calif. and CARLOW, Ireland, Dec. 17, 2025 /PRNewswire/ — Netwatch (the “Company”), a global provider of AI-powered security services, announced today that it has signed a definitive agreement to be acquired by GI Partners. Netwatch is a leading global provider of intelligent security solutions, serving a broad range of verticals, including organizations in… Continue reading Netwatch Announces Agreement to Be Acquired by GI Partners